| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |